May 2018
Advocacy Payer Toolkit

SCMR is excited to launch a new  Advocacy page on the website. This page was developed to provide members with additional resources in your interactions with private and public payers. The Payer Toolkit will assist you in interactions with public and private payers by providing guidelines, CMR codes and descriptors, policies, and more. The page also highlights all of the efforts SCMR is addressing on behalf of the members. We hope you find this new resource valuable and welcome your suggestions on additional resources. 
Why CMR - Safety 

The new Why CMR section of the website was developed to offer members a collection of resources that demonstrates the areas where CMR has distinct advantages. Over the next few months, SCMR will be highlighting the safety aspects: magnetic field, radiation-free, contrast, devices, and pregnancy. Please support these efforts by using the #WhyCMR to help spread the word on the value of CMR.
Deadline June 1st               
CEO Candidate Search

As announced previously, current Chief Executive Officer Orlando Simonetti is stepping down following the 2019 Scientific Sessions. The SCMR is currently accepting applications from interested candidates. The CEO position description, responsibilities, and requirements have been posted. The deadline to submit your information is August 1st. The SCMR Executive Committee and Board of Trustees will be reviewing and interviewing final candidates.
Case of the Week
Levoatriocardinal Vein with Normal Intracardiac Anatomy: A Case of Misidentification

A 39-year-old male with a history of obesity and poorly controlled essential hypertension presented to the emergency department with chest pain and shortness of breath. A CT angiogram demonstrated normal coronary anatomy. However, a vascular structure was noted coursing from the innominate vein toward the left atrium (Image 1). This was interpreted as a persistent left superior vena cava (LSVC) with intact bridging vein. The patient was referred to a cardiologist for further evaluation of his symptoms and management of his hypertension. 2-dimensional (2D) transesophageal echocardiogram (TEE) demonstrated a structurally normal heart, mild qualitative dilation of the left atrium (LA), and no apparent atrial or ventricular septal defects. There was no significant atrioventricular valve insufficiency. The right ventricle (RV) and left ventricle (LV) were normal in regards to size, global systolic function, and regional wall motion. A bubble contrast study was performed to exclude intracardiac shunting.

JCMR Articles

Kady Fischer, et al.
Published on: 7 May 2018